← Open Payments lookup

KRISTA BROWN: Open Payments

NPI 1629435177 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,059 in 33 payments from 15 companies in 2025. Trend: 2023 $508 · 2024 $1,392 · 2025 $1,059

Food & beverage: $1,059
CompanyPaymentsAmount
Novo Nordisk Inc6$229
AstraZeneca Pharmaceuticals LP5$172
GlaxoSmithKline, LLC.2$144
Alnylam Pharmaceuticals Inc.1$122
Lilly USA, LLC6$110
Gilead Sciences, Inc.2$46
PFIZER INC.2$44
ABBVIE INC.2$41
Takeda Pharmaceuticals U.S.A., Inc.1$28
Dexcom, Inc.1$25

Products named: AREXVY, AMVUTTRA, Wegovy, BREZTRI, Ozempic, MOUNJARO, AIRSUPRA, VYNDAQEL.

Industry payments across MD — which companies pay providers there.